Dantrolene sodium is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 µM and an IC50 of 52.3 µM. Dantrolene sodium is also a calcium channel protein inhibitor. Dantrolene sodium inhibits the release of Ca2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis.
Molecular Weight:
336.23
Purity:
99.74%
CAS Number:
[14663-23-1]
Formula:
C14H9N4NaO5
Target:
Calcium Channel
* VAT and and shipping costs not included. Errors and price changes excepted
